IBDEI0CZ ; ; 20-FEB-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 20, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17287,0)
 ;;=285.29^^125^1075^9
 ;;^UTILITY(U,$J,358.3,17287,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17287,1,4,0)
 ;;=4^285.29
 ;;^UTILITY(U,$J,358.3,17287,1,5,0)
 ;;=5^Anemia Of Chronic Dis
 ;;^UTILITY(U,$J,358.3,17287,2)
 ;;=^321979
 ;;^UTILITY(U,$J,358.3,17288,0)
 ;;=284.9^^125^1075^10
 ;;^UTILITY(U,$J,358.3,17288,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17288,1,4,0)
 ;;=4^284.9
 ;;^UTILITY(U,$J,358.3,17288,1,5,0)
 ;;=5^Aplastic Anemia Nos
 ;;^UTILITY(U,$J,358.3,17288,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,17289,0)
 ;;=282.61^^125^1075^66
 ;;^UTILITY(U,$J,358.3,17289,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17289,1,4,0)
 ;;=4^282.61
 ;;^UTILITY(U,$J,358.3,17289,1,5,0)
 ;;=5^Hemoglobin S Disease
 ;;^UTILITY(U,$J,358.3,17289,2)
 ;;=^267981
 ;;^UTILITY(U,$J,358.3,17290,0)
 ;;=282.7^^125^1075^65
 ;;^UTILITY(U,$J,358.3,17290,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17290,1,4,0)
 ;;=4^282.7
 ;;^UTILITY(U,$J,358.3,17290,1,5,0)
 ;;=5^Hemoglobin C Disease
 ;;^UTILITY(U,$J,358.3,17290,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,17291,0)
 ;;=283.9^^125^1075^68
 ;;^UTILITY(U,$J,358.3,17291,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17291,1,4,0)
 ;;=4^283.9
 ;;^UTILITY(U,$J,358.3,17291,1,5,0)
 ;;=5^Hemolytic Anemia , Acquired
 ;;^UTILITY(U,$J,358.3,17291,2)
 ;;=^7071
 ;;^UTILITY(U,$J,358.3,17292,0)
 ;;=283.0^^125^1075^69
 ;;^UTILITY(U,$J,358.3,17292,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17292,1,4,0)
 ;;=4^283.0
 ;;^UTILITY(U,$J,358.3,17292,1,5,0)
 ;;=5^Hemolytic Anemia, Autoimmune
 ;;^UTILITY(U,$J,358.3,17292,2)
 ;;=^7079
 ;;^UTILITY(U,$J,358.3,17293,0)
 ;;=282.9^^125^1075^67
 ;;^UTILITY(U,$J,358.3,17293,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17293,1,4,0)
 ;;=4^282.9
 ;;^UTILITY(U,$J,358.3,17293,1,5,0)
 ;;=5^Hemolytic Anem, Heredit
 ;;^UTILITY(U,$J,358.3,17293,2)
 ;;=^56578
 ;;^UTILITY(U,$J,358.3,17294,0)
 ;;=283.19^^125^1075^70
 ;;^UTILITY(U,$J,358.3,17294,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17294,1,4,0)
 ;;=4^283.19
 ;;^UTILITY(U,$J,358.3,17294,1,5,0)
 ;;=5^Hemolytic Anemia, Microang
 ;;^UTILITY(U,$J,358.3,17294,2)
 ;;=^293664
 ;;^UTILITY(U,$J,358.3,17295,0)
 ;;=280.9^^125^1075^74
 ;;^UTILITY(U,$J,358.3,17295,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17295,1,4,0)
 ;;=4^280.9
 ;;^UTILITY(U,$J,358.3,17295,1,5,0)
 ;;=5^Iron Defic Anemia(Unspecified)
 ;;^UTILITY(U,$J,358.3,17295,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,17296,0)
 ;;=285.1^^125^1075^72
 ;;^UTILITY(U,$J,358.3,17296,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17296,1,4,0)
 ;;=4^285.1
 ;;^UTILITY(U,$J,358.3,17296,1,5,0)
 ;;=5^Iron Defic Anemia Due To Acute Blood Loss
 ;;^UTILITY(U,$J,358.3,17296,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,17297,0)
 ;;=280.0^^125^1075^73
 ;;^UTILITY(U,$J,358.3,17297,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17297,1,4,0)
 ;;=4^280.0
 ;;^UTILITY(U,$J,358.3,17297,1,5,0)
 ;;=5^Iron Defic Anemia Due To Chronic Blood Loss
 ;;^UTILITY(U,$J,358.3,17297,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,17298,0)
 ;;=281.9^^125^1075^92
 ;;^UTILITY(U,$J,358.3,17298,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17298,1,4,0)
 ;;=4^281.9
 ;;^UTILITY(U,$J,358.3,17298,1,5,0)
 ;;=5^Nutritional Anemia
 ;;^UTILITY(U,$J,358.3,17298,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,17299,0)
 ;;=281.0^^125^1075^109
 ;;^UTILITY(U,$J,358.3,17299,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17299,1,4,0)
 ;;=4^281.0
 ;;^UTILITY(U,$J,358.3,17299,1,5,0)
 ;;=5^Vit B12 Deficiency (Pernicious Anemia)
 ;;^UTILITY(U,$J,358.3,17299,2)
 ;;=^7161
 ;;^UTILITY(U,$J,358.3,17300,0)
 ;;=282.60^^125^1075^99
 ;;^UTILITY(U,$J,358.3,17300,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17300,1,4,0)
 ;;=4^282.60
 ;;^UTILITY(U,$J,358.3,17300,1,5,0)
 ;;=5^Sickle-Cell Anemia
 ;;^UTILITY(U,$J,358.3,17300,2)
 ;;=^7188
 ;;^UTILITY(U,$J,358.3,17301,0)
 ;;=282.62^^125^1075^100
 ;;^UTILITY(U,$J,358.3,17301,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17301,1,4,0)
 ;;=4^282.62
 ;;^UTILITY(U,$J,358.3,17301,1,5,0)
 ;;=5^Sickle-Cell With Crisis
 ;;^UTILITY(U,$J,358.3,17301,2)
 ;;=^267982
 ;;^UTILITY(U,$J,358.3,17302,0)
 ;;=281.1^^125^1075^110
 ;;^UTILITY(U,$J,358.3,17302,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17302,1,4,0)
 ;;=4^281.1
 ;;^UTILITY(U,$J,358.3,17302,1,5,0)
 ;;=5^Vit B12 Deficiency(Dietary)
 ;;^UTILITY(U,$J,358.3,17302,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,17303,0)
 ;;=286.7^^125^1075^44
 ;;^UTILITY(U,$J,358.3,17303,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17303,1,4,0)
 ;;=4^286.7
 ;;^UTILITY(U,$J,358.3,17303,1,5,0)
 ;;=5^Coagulation Defect(Any),Acquired
 ;;^UTILITY(U,$J,358.3,17303,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,17304,0)
 ;;=289.9^^125^1075^106
 ;;^UTILITY(U,$J,358.3,17304,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17304,1,4,0)
 ;;=4^289.9
 ;;^UTILITY(U,$J,358.3,17304,1,5,0)
 ;;=5^Thrombocytosis, Essential
 ;;^UTILITY(U,$J,358.3,17304,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,17305,0)
 ;;=451.9^^125^1075^107
 ;;^UTILITY(U,$J,358.3,17305,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17305,1,4,0)
 ;;=4^451.9
 ;;^UTILITY(U,$J,358.3,17305,1,5,0)
 ;;=5^Thrombophlebitis 
 ;;^UTILITY(U,$J,358.3,17305,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,17306,0)
 ;;=446.6^^125^1075^108
 ;;^UTILITY(U,$J,358.3,17306,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17306,1,4,0)
 ;;=4^446.6
 ;;^UTILITY(U,$J,358.3,17306,1,5,0)
 ;;=5^Thrombotic Thrombocytopenic Purpura(Ttp)
 ;;^UTILITY(U,$J,358.3,17306,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,17307,0)
 ;;=286.4^^125^1075^111
 ;;^UTILITY(U,$J,358.3,17307,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17307,1,4,0)
 ;;=4^286.4
 ;;^UTILITY(U,$J,358.3,17307,1,5,0)
 ;;=5^Von Willebrand'S Disease
 ;;^UTILITY(U,$J,358.3,17307,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,17308,0)
 ;;=204.00^^125^1075^4
 ;;^UTILITY(U,$J,358.3,17308,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17308,1,4,0)
 ;;=4^204.00
 ;;^UTILITY(U,$J,358.3,17308,1,5,0)
 ;;=5^All, W/O Remission
 ;;^UTILITY(U,$J,358.3,17308,2)
 ;;=^267521
 ;;^UTILITY(U,$J,358.3,17309,0)
 ;;=204.01^^125^1075^3
 ;;^UTILITY(U,$J,358.3,17309,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17309,1,4,0)
 ;;=4^204.01
 ;;^UTILITY(U,$J,358.3,17309,1,5,0)
 ;;=5^All, In Remission
 ;;^UTILITY(U,$J,358.3,17309,2)
 ;;=^267522
 ;;^UTILITY(U,$J,358.3,17310,0)
 ;;=204.10^^125^1075^41
 ;;^UTILITY(U,$J,358.3,17310,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17310,1,4,0)
 ;;=4^204.10
 ;;^UTILITY(U,$J,358.3,17310,1,5,0)
 ;;=5^Cll, W/O Remission
 ;;^UTILITY(U,$J,358.3,17310,2)
 ;;=^267523
 ;;^UTILITY(U,$J,358.3,17311,0)
 ;;=204.11^^125^1075^40
 ;;^UTILITY(U,$J,358.3,17311,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17311,1,4,0)
 ;;=4^204.11
 ;;^UTILITY(U,$J,358.3,17311,1,5,0)
 ;;=5^Cll, In Remission
 ;;^UTILITY(U,$J,358.3,17311,2)
 ;;=^267524
 ;;^UTILITY(U,$J,358.3,17312,0)
 ;;=201.90^^125^1075^71
 ;;^UTILITY(U,$J,358.3,17312,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17312,1,4,0)
 ;;=4^201.90
 ;;^UTILITY(U,$J,358.3,17312,1,5,0)
 ;;=5^Hodgkin'S Lymphoma, Unpsec Type & Site
 ;;^UTILITY(U,$J,358.3,17312,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,17313,0)
 ;;=785.6^^125^1075^77
 ;;^UTILITY(U,$J,358.3,17313,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17313,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,17313,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,17313,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,17314,0)
 ;;=200.20^^125^1075^78
 ;;^UTILITY(U,$J,358.3,17314,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17314,1,4,0)
 ;;=4^200.20
 ;;^UTILITY(U,$J,358.3,17314,1,5,0)
 ;;=5^Lymphoma, Burkitt'S, Unspecified Sites
 ;;^UTILITY(U,$J,358.3,17314,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,17315,0)
 ;;=202.00^^125^1075^80
 ;;^UTILITY(U,$J,358.3,17315,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17315,1,4,0)
 ;;=4^202.00
 ;;^UTILITY(U,$J,358.3,17315,1,5,0)
 ;;=5^Lymphoma, Low-Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,17315,2)
 ;;=^72606
 ;;^UTILITY(U,$J,358.3,17316,0)
 ;;=200.10^^125^1075^79
 ;;^UTILITY(U,$J,358.3,17316,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17316,1,4,0)
 ;;=4^200.10
 ;;^UTILITY(U,$J,358.3,17316,1,5,0)
 ;;=5^Lymphoma, Int Or High Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,17316,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,17317,0)
 ;;=273.3^^125^1075^81
 ;;^UTILITY(U,$J,358.3,17317,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17317,1,4,0)
 ;;=4^273.3
 ;;^UTILITY(U,$J,358.3,17317,1,5,0)
 ;;=5^Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,17317,2)
 ;;=^73013
 ;;^UTILITY(U,$J,358.3,17318,0)
 ;;=203.00^^125^1075^90
 ;;^UTILITY(U,$J,358.3,17318,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17318,1,4,0)
 ;;=4^203.00
 ;;^UTILITY(U,$J,358.3,17318,1,5,0)
 ;;=5^Multiple Myeloma W/O Rem
 ;;^UTILITY(U,$J,358.3,17318,2)
 ;;=^267514
 ;;^UTILITY(U,$J,358.3,17319,0)
 ;;=203.01^^125^1075^89
 ;;^UTILITY(U,$J,358.3,17319,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17319,1,4,0)
 ;;=4^203.01
 ;;^UTILITY(U,$J,358.3,17319,1,5,0)
 ;;=5^Multiple Myeloma In Remission
 ;;^UTILITY(U,$J,358.3,17319,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,17320,0)
 ;;=238.6^^125^1075^93
 ;;^UTILITY(U,$J,358.3,17320,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17320,1,4,0)
 ;;=4^238.6
 ;;^UTILITY(U,$J,358.3,17320,1,5,0)
 ;;=5^Plasmacytoma Nos
 ;;^UTILITY(U,$J,358.3,17320,2)
 ;;=^81973
 ;;^UTILITY(U,$J,358.3,17321,0)
 ;;=205.00^^125^1075^6
 ;;^UTILITY(U,$J,358.3,17321,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17321,1,4,0)
 ;;=4^205.00
 ;;^UTILITY(U,$J,358.3,17321,1,5,0)
 ;;=5^Aml, W/O Remission
 ;;^UTILITY(U,$J,358.3,17321,2)
 ;;=^267531
 ;;^UTILITY(U,$J,358.3,17322,0)
 ;;=205.01^^125^1075^5
 ;;^UTILITY(U,$J,358.3,17322,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17322,1,4,0)
 ;;=4^205.01
 ;;^UTILITY(U,$J,358.3,17322,1,5,0)
 ;;=5^Aml, In Remission
 ;;^UTILITY(U,$J,358.3,17322,2)
 ;;=^267532
 ;;^UTILITY(U,$J,358.3,17323,0)
 ;;=205.10^^125^1075^43
 ;;^UTILITY(U,$J,358.3,17323,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17323,1,4,0)
 ;;=4^205.10
 ;;^UTILITY(U,$J,358.3,17323,1,5,0)
 ;;=5^Cml, W/O Remission
